Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & Colin Tan
  • October 1, 2019
  • Webinars

Webcast: Portfolio analysis - Choosing your communication strategy

Webcast: Portfolio analysis - Choosing your communication strategy

Portfolio Analysis and Optimization concentrates on determining the impact that multiple assets have within therapeutic categories, and how the marketing of these assets impacts on overall strategy. This is an important tool for pharmaceutical companies in today’s market. As they simultaneously develop multiple products that can become extremely costly, portfolio management to improve decision-making can have a significant impact on the bottom line. At its very core, it is about selecting how to allocate resources and marketing efforts across multiple assets. 

read more »

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

Our client had their product  for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering strategies to manage combination therapies in the future. Therefore, they wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.

read more »

How we helped assess the asthma market landscape in emerging markets

How we helped assess the asthma market landscape in emerging markets

Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape.

read more »

The vaccine opportunity in Asia infographic

The vaccine opportunity in Asia infographic

Asia is the home to 60% of the world’s population and is one of the fastest growing vaccine markets in the world. A rising demand for better healthcare infrastructure and high awareness levels of the benefits of immunisation are the major factors boosting the vaccine market growth. In our latest infographic we explore the vaccine opportunity in Asia, packed full with all of the latest facts and figures from the region.

read more »

  • Posted by Phil Rosenberg
  • September 24, 2019
  • News

Chicago Intellus Regional Event round up 2019

Chicago Intellus Regional Event round up 2019

On 11th September, Director, Phil Rosenberg and about 60 other delegates attended the first Intellus regional event hosted in the beautiful Chicago Botanical Gardens.

read more »